StreetAlpha
13F holdings · Q3 2026

Braidwell

Stamford, CT · files as Braidwell LP
Know the moment Braidwell filesYou follow Braidwell An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1920938

Braidwell reported 86 stocks worth $2.3B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are KOD (4.4%), CAI (3.6%) and EWTX (3.6%). Compared with Q2 2026, the fund opened new positions in DMRA, NVCT and TEVA, added to EWTX, ATEC and XENE, trimmed KOD, CAI and IRTC and sold out of ACAD, CDNA and DYN.

Latest filing: what Braidwell did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
16 new19 added38 trimmed13 sold outBought about $371M · sold about $829M
New 16
See all 16 →
Added 19
See all 19 →
Trimmed 38
  • CAI−$169M−67%
  • KOD−$66.5M−39%
  • HNGE−$65.6M−51%
  • GKOS−$40.7M−42%
  • TMO−$32.2M−53%
See all 38 →
Sold out 13
See all 13 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$2.3B−10.8% vs last quarter
Stocks held8616 new · 13 sold out
Top 5 weight18.0%spread out
Turnover52%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
KOD
Kodiak Sciences Inc
$103M4.4%1.1M−702K (−39%)4 of 8
2
CAI
Caris Life Sciences Inc
$84.1M3.6%2.7M−5.5M (−67%)6 of 8
3
EWTX
Edgewise Therapeutics Inc
$84M3.6%2.1M+72K (+4%)8 of 8
4
ATEC
Alphatec Hldgs Inc
$74.6M3.2%7.2M+697K (+11%)7 of 8
5
IRTC
Irhythm Technologies Inc
$72.8M3.1%641K−14K (−2%)8 of 8
6
HNGE
Hinge Health Inc
$63.7M2.7%655K−675K (−51%)5 of 8
7
SYRE
Spyre Therapeutics Inc
$63.6M2.7%714K−166K (−19%)8 of 8
8
XENE
Xenon Pharmaceuticals Inc
$63.5M2.7%1.7M+577K (+51%)8 of 8
9
NEO
Neogenomics Inc
$61.5M2.6%3.3M−1.6M (−32%)5 of 8
10
GKOS
Glaukos Corp
$56.5M2.4%344K−248K (−42%)8 of 8
🔒 76 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
GALECTO INC
$42.1M1.6M
ACAD
Acadia Pharmaceuticals Inc
$41.7M1.6M
CDNA
Caredx Inc
$34.8M1.2M
DYN
Dyne Therapeutics Inc
$20.5M922K
ARGX
Argenx SE
$16.4M18K

🔒 Free account: see all 13.

Reported value

last 8 quarters
$2.2BQ4 '24
$1.9BQ1 '25
$2.1BQ2 '25
$2.5BQ3 '25
$2.6BQ4 '25
$2.6BQ1 '26
$2.6BQ2 '26
$2.3BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Braidwell 13F FAQ

What does Braidwell own?

Braidwell reported 86 stocks worth $2.3B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are KOD (4.4%), CAI (3.6%) and EWTX (3.6%). The table above lists every position in the filing (the top 10 without an account).

What did Braidwell buy and sell in Q3 2026?

Compared with Q2 2026: 16 new positions, 19 added to, 38 trimmed and 13 sold out. New positions include DMRA, NVCT and TEVA. It sold all of ACAD, CDNA and DYN.

When will Braidwell file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Braidwell's portfolio worth?

The Q3 2026 filing reports $2.3B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.